Partial hepatectomy in rats results in significant growth of liver metastases by increased expression of H19 gene

Cancer Therapy

Volumn 7, Issue ISSUE A, 2009, Pages 240-244

  Sorin, Vladimir ^a   Mizrahi, Aya ^b   Ohana, Patricia ^b   Ayesh, Suhail ^b   Birman, Tatiana ^b   Hochberg, Abraham ^b   Czerniak, Abraham ^a  

^a WOLFSON MEDICAL CENTER   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Hepatectomy; Liver metastases; RNA isolation and cDNA synthesis; RNA products of H19 and HGF

Indexed keywords

RNA H19; SCATTER FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CANCER GROWTH; COLON CANCER; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE INTERACTION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; LIVER METASTASIS; MALE; NONHUMAN; PARTIAL HEPATECTOMY; POSTOPERATIVE COMPLICATION; RAT; REVIEW; RNA ANALYSIS; SURGICAL TECHNIQUE; TUMOR VOLUME;

EID: 69949142049     PISSN: 15439135     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. Adriaenssens E, Dumont L, Lottin S, Bolle D, Leprêtre A, Delobelle A, Bouali F, Dugimont T, Coll J, Curgy JJ (1998) H19 overexpression in breast adenocarcinoma stromal cell is associated with tumor values and steroid receptor status but independent of p53 and Ki-67 expression. Am J Pathol 153, 1597-1607.
2. Adriaenssens E, Lottin S, Berteaux N, Hornez L, Fauquette W, Fafeur V, Peyrat JP, Le Bourhis X, Hondermarck H, Coll J, Dugimont T, Curgy JJ (2002) Cross-talk between mesenchyme and epithelium increases H19 gene expression during scattering and morhogenesis of epithelial cells. Exp Cell Res 275, 215-229.
3. Ariel I, Ayesh S, Perlman EJ, Pizov G, Tanos V, Schneider T, Erdmann VA, Podeh D, Komitowski D, Quasem AS, de Groot N, Hochberg A (1997) The product of the imprinted H19 gene is an oncofetal RNA. Mol Pathol 50, 34-44.
4. Ariel I, Lusting O, Schneider T, Pizov G, Sappir M, De-Groot N and Hochberg A (1995) The imprinted H19 gene as a tumor marker in bladder carcinoma. Urology 45, 335-338.
5. Ariel I, Miao HQ, Ji XR Schneider T, Roll D, de Groot N, Hochberg A, Ayesh S (1998) Imprinted H19 oncofetal RNA is a candidate tumor marker for hepatocellular carcinoma. Mol Pathol 51, 21-25.
6. Ayesh B, Matouk I, Ohana P, Sughayer MA, Birman T, Ayesh S, Schneider T, de Groot N, Hochberg A (2003) Inhibition of tumor growth by DT-A expressed under the control of IGF2 P3 and P4 promoter sequences. Mol Ther 7, 535-541.
7. Ayesh S, Matouk I, Schneider T, Ohana P, Laster M, Al-Sharef W, De-Groot N and Hochberg A (2002) The possible physiological role of H19 RNA. Mol Carcinog 35, 63-74.
8. Cooper MJ, Fischer M, Komitowski D, Shevelev A, Schulze E, Ariel I, Tykocinski ML, Miron S, Ilan J, de Groot N, Hochberg A (1996) Developmentally imprinted genes as markers for bladder tumor progression. J Urol 155, 2120-2127.
9. de Jong KP, Lont HE, Bijma AM, Brouwers MA, de Vries EG, van Veen ML, Marquet RL, Slooff MJ Terpstra OT (1995) The effect of partial hepatectomy on tumor growth in rats: in vivo and in vitro studies. Hepatology 22, 1263-1272.
10. Elias D, De Baere T, Roche A, Ducreux M, Leclere J, Lasser P (1999) During liver regeneration following right portal embolization growth rate of liver metastases is more rapid than that of the liver parenchyma. Br J Surg 86, 784-788.
11. Elias D, Debaere T, Roche A, Bonvallot S, Lasser P (1998) Preoperative selective portal vein embolization are an effective means of extending in indications of major hepatectomy in the normal and injured liver. Hepatogastroenterology 45, 170-177.
12. Erdmann VA, Barciszewska MZ, Szymanski M, Hochberg A, de Groot N and Barciszewski J (2001) The non-coding RNAs as riboregulators. Nucleic Acids Res 29, 189-193.
13. Fellig Y, Ariel I, Ohana P, Schachter P, Sinelnikov I, Birman T, Ayesh S, Schneider T, de Groot N, Czerniak A, Hochberg A. (2005) H19 expression in hepatic metastases from a range of human carcinomas. J Clin Pathol 58, 1064-1068.
14. Garcia-Alonso I, Palomares T, Alonso A, Portugal V, Castro B, Caramés J, Méndez J (2003) Effect of hepatic resection on development of liver metastasis. Rev Esp Enferm Dig 95, 765-770.
15. Guirouilh J, Castroviejo M, Balabaud C, Desmouliere A, Rosenbaum J (2000) Hepatocarcinoma cells stimulate hepatocyte growth factor secretion in human liver myofibroblasts. Int J Oncol 17, 777-781.
16. Higgins G, Anderson R (1931) Experimental pathology of the liver.I. Restoration of the liver of the white rat following partial surgical removal. Arch Pathol 12, 186-202.
17. Hochberg A (2005) The Oncofetal H19 RNA in human cancer, from the bench to the patient. Cancer Therapy 3, 1-18.
18. Ikeda Y, Matsumata T, Takenaka K, Sasaki O, Soejima K, and Sugimachi K (1995) Preliminary report of tumor metastasis during liver regeneration after hepatic resection in rats. Eur J Surg Oncol 21, 188-190.
19. Jiang WG, Hallet MB, Puntis MC (1993) Hepatocyte growth factor/ Scatter factor, liver regeneration and cancer metastasis. Br J Surg 80, 1368-1373.
20. Kamiyama T, Une Y, Uchino J, Hamada J (1998) Hepatocyte growth factor enhances the invasion activity of human hepatocellular carcinoma cell lines. Int J Oncol 12, 655-659.
21. Matouk I, Ohana P, Ayesh S, Sidi A, Czerniak A, de Groot N, Matsumoto K, NaKamura T (1993) Roles of HGF as a pleiotropic factor in organ regeneration. In Goldberg ID, Rosen EM (eds.): Hepatocyte growth factor - scatter factor (HGF-SF) and the C-met receptor. Basel: Birkhauser Verlag 225-249.
22. Michalopoulos GK, Appasamy R (1993) Metabolism of HGF-SF and its role in liver regeneration. EXS 65, 275-283.
23. Miyata K, Taniguchi H, Takeuchi K, Koyama H, Tanaka H, Takahashi T (1996) Weight of resected liver is positively correlated with serum hHGF level. Hepatogastroenterology 43, 1589-1593.
24. Ohana P, Schachter P, Ayesh B, Mizrahi A, Birman T, Schneider T, Matouk I, Ayesh S, Kuppen PJ, de Groot N, Czerniak A, Hochberg A (2005) Regulatory sequences of H19 and IGF2 genes in DNA-based therapy of colorectal rat liver metastases. J Gene Med 7, 366-374.
25. Pachnis V, Brannan CI, Tilghman SM (1988) The structure and expression of a novel gene activated in early mouse embryogenesis. EMBO J 7, 673-681.
26. Panis Y, Ribeiro J, Chretien Y, Nordlinger B (1992) Dormant liver metastases: an experimental study. Br J Surg 79, 221-223.
27. Poirier F, Chan CT, Timmons, PM Robertson EJ, Evans MJ, Rigby PW (1991) The murine H19 gene is activated during embryonic stem cell differentiation in vitro and at the time of implantation in the developing embryo. Development 113, 1105-1114.
28. Rachmilewitz J, Elkin M, Rosensaft J, Gelman-Kohan Z, Ariel I, Lustig O, Schneider T, Goshen R, Biran H, de Groot N (1995) H19 expression and tumorigenicity of choriocarcinoma derived cell lines. Oncogene 11, 863-870.
29. Santoni-Rugiu E, Preisegger KH, Kiss A, Audolfsson T, Shiota G, and Schmidt EV, Thorgeirsson SS (1996) Inhibition of neoplastic development in the liver by hepatocyte growth factor in a transgenic mouse model. Proc Natl Acad Sci USA 93, 9577-9582.
30. Schlag PM, Benhidjeb T, Stroszczynski C (2002) Resection and local therapy for liver metastases. Best Pract Res Clin Gastroenterol 16, 299-317.
31. Tajima H, Matsumoto K, and NaKamura T (1991) Hepatocyte growth factor has a potent antiproliferative activity in various tumor cell lines. FEBS Lett 291, 229-232.
32. Thorgeirsson SS, Santoni-Rugiu E (1996) Transgenic mouse model in carcinogenesis: interaction of c-myc with transforming growth factor alpha and hepatocyte growth factor in hepatocarcinogenesis. Br J Clin Pharmacol 42, 43-52.
33. von Schweinitz D, Fuchs J, Gluer S, Pietsch T (1998) The occurrence of liver growth factor in hepatoblastoma. Eur J Pediatr Surg 8, 133-136.
34. Yamamoto Y, Nishikawa Y, Tokairin T, Omori Y, Enomoto K (2004) Increased expression of H19 non-coding mRNA follows hepatocyte proliferation in the rat and mouse. J Hepatol 40, 808-814.